论文部分内容阅读
目的评价多沙唑嗪控释片在前列腺电切术后应用的疗效。方法将87例接受前列腺电切术患者随机分为对照组(A组)和多沙唑嗪控释片组(B组),A组术后未作特殊处理,B组术后常规口服多沙唑嗪,4 mg/d,服用3个月,分别于术前、术后1个月、3个月、6个月接受IPSS评估,比较两组IPSS评分的统计学差异。结果术前两组IPSS评分的差异无统计学意义(P>0.05),术后1个月、3个月、6个月IPSS评分A组>B组(P<0.05)。结论多沙唑嗪能有效缓解前列腺电切术后患者下尿路症状。
Objective To evaluate the efficacy of doxazosin controlled release tablets after prostatectomy. Methods Eighty-seven patients undergoing prostatectomy were randomly divided into control group (group A) and doxazosin controlled-release group (group B). No special treatment was given in group A after operation. Conventional oral administration of sand 4 mg / d for 3 months. IPSS was evaluated preoperatively, 1 month, 3 months and 6 months postoperatively. The statistical differences between the two groups were compared. Results There was no significant difference in IPSS score between the two groups before surgery (P> 0.05). The IPSS score of group A at 1 month, 3 months and 6 months after operation was significantly higher than that of group B (P <0.05). Conclusion Doxazosin can effectively relieve the symptoms of lower urinary tract in patients after prostatectomy.